Zenas BioPharma, Inc. ZBIO
28.57 USD +0.31 (+1.10%)
At closeNov 10, 2026, 4:16 AM EST
28.01 -0.56 -1.96%
Pre-market · Nov 10, 4:16 AM ET
27.80 Day range 30.02
13.50 52-week range 44.60
- YTD
- -21.32%
- 1 year
- -12.01%
News
benzinga.com Zenas BioPharma Q3 EPS $(1.65) Misses $(1.33) Estimate, Sales $10.000M Zenas BioPharma (NASDAQ:ZBIO) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(1.33) by 24.06 percent. This is a 35.25 percent decrease over losses of…
globenewswire.com Zenas BioPharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update - PDUFA target action date of May 27, 2027, following FDA acceptance of obexelimab BLA submission for the treatment of IgG4-RD in August 2026 - - Obexelimab MAA submitted to the EMA for the treatment…
defenseworld.net Head-To-Head Review: BioCryst Pharmaceuticals (NASDAQ:BCRX) & Zenas BioPharma (NASDAQ:ZBIO) BioCryst Pharmaceuticals (NASDAQ: BCRX - Get Free Report) and Zenas BioPharma (NASDAQ: ZBIO - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two…
benzinga.com HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target HC Wainwright & Co. analyst Matthew Caufield reiterates Zenas BioPharma (NASDAQ:ZBIO) with a Buy and maintains $44 price target.- benzinga.com Zenas BioPharma Presents New Obexelimab Data In Immunoglobulin G4-Related Disease At 6th International Symposium On IgG4-Related Disease – Phase 3 INDIGO open-label extension findings demonstrated sustained clinical activity of obexelimab –– Additional analyses of secondary endpoints showed that significantly fewer patients…
benzinga.com Citigroup Maintains Buy on Zenas BioPharma, Raises Price Target to $48 Citigroup analyst Yigal Nochomovitz maintains Zenas BioPharma (NASDAQ:ZBIO) with a Buy and raises the price target from $41 to $48.- benzinga.com Wedbush Reiterates Outperform on Zenas BioPharma, Maintains $45 Price Target Wedbush analyst Martin Fan reiterates Zenas BioPharma (NASDAQ:ZBIO) with a Outperform and maintains $45 price target.
- benzinga.com HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target HC Wainwright & Co. analyst Matthew Caufield reiterates Zenas BioPharma (NASDAQ:ZBIO) with a Buy and maintains $44 price target.
benzinga.com Zenas BioPharma To Present New Data From Phase 3 INDIGO Trial Evaluating Obexelimab In IgG4-RD At 6th International Symposium On IgG4-Related Disease, And ACR Convergence 2026 – New data from the Phase 3 INDIGO open-label extension will include the longer-term flare protection and safety data of obexelimab in IgG4-RD –– Additional analyses will assess…
benzinga.com Zenas BioPharma Registers Resale Of Up To 7M Shares By Selling Stocholder ZENAS BIOPHARMA, INC.Up to 7,000,000 Shares of Common StockThis prospectus relates to the resale or other disposition from time to time of up to 7,000,000 shares (the "Shares") of our common stock,…
benzinga.com Morgan Stanley Maintains Equal-Weight on Zenas BioPharma, Raises Price Target to $32 Morgan Stanley analyst Judah Frommer maintains Zenas BioPharma (NASDAQ:ZBIO) with a Equal-Weight and raises the price target from $22 to $32.
benzinga.com Guggenheim Reiterates Buy on Zenas BioPharma, Maintains $55 Price Target Guggenheim analyst Yatin Suneja reiterates Zenas BioPharma (NASDAQ:ZBIO) with a Buy and maintains $55 price target.- benzinga.com Wedbush Reiterates Outperform on Zenas BioPharma, Maintains $45 Price Target Wedbush analyst Martin Fan reiterates Zenas BioPharma (NASDAQ:ZBIO) with a Outperform and maintains $45 price target.
benzinga.com Zenas BioPharma Q2 EPS $(1.77) Misses $(1.08) Estimate, Sales $1.000M Miss $18.750M Estimate Zenas BioPharma (NASDAQ:ZBIO) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.08) by 63.89 percent. This is a 41.6 percent decrease over losses of…
benzinga.com Lennar Reports Mixed Q2 Results, Joins Adobe And Other Big Stocks Moving Lower In Friday's Pre-Market Session US stock futures rise, Dow futures up 300 points. Lennar Corp falls after reporting mixed Q2 results. Other stocks declining in pre-market trading.
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com Alpha Buying: Insider Conviction in High-Risk Biotech 
benzinga.com Crude Oil Surges 4%; US Consumer Sentiment Declines In March U.S. stocks down, NASDAQ drops 1.5% on Friday. Energy shares up, consumer discretionary down. University of Michigan's Consumer Sentiment Index falls.
benzinga.com Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Why Newsmax Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-market gainers include ONCO, VSA, GMEX, IZM, GVH, BATL, U, SGML, & GLND. Losers are SLND, DTCX, TOP, SVRN,…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday 
benzinga.com Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com US Stocks Higher; Dow Jumps 250 Points - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 
benzinga.com This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday